Monoclonal antibodies in haemato-oncology [electronic resource] / Mark Cragg.
Material type:![Film](/opac-tmpl/lib/famfamfam/VM.png)
Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Introduction to the development and clinical use of monoclonal antibodies (mAb) in haemato-oncology -- Currently approved mAb for treating cancer -- Direct targeting antibodies -- Rituximab -- Fc gamma receptors (FcgR) as key mediators of cellular immunity -- Macrophages as key effector cells -- B cell deletion as a paradigm for mAb effects -- Type I versus Type II antibodies -- Obinutuzumab -- Immunomodulatory mAb -- Combinations between direct targeting and immunomodulatory mAb.
Access restricted to subscribers.
Mode of access: World Wide Web.